| Hyperthermic intraperitoneal chemotherapy in ovarian cancer WJ Van Driel, SN Koole, K Sikorska, JH Schagen van Leeuwen, ... New England Journal of Medicine 378 (3), 230-240, 2018 | 1349 | 2018 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017 | 1121 | 2017 |
| Type I and II endometrial cancers: have they different risk factors? VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ... Journal of Clinical Oncology 31 (20), 2607-2618, 2013 | 907 | 2013 |
| Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ... Nature medicine 25 (6), 920-928, 2019 | 708 | 2019 |
| Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma MÁ Castilla, G Moreno‐Bueno, L Romero‐Pérez, KV De Vijver, ... The Journal of pathology 223 (1), 72-80, 2011 | 273 | 2011 |
| Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group C Denkert, S Wienert, A Poterie, S Loibl, J Budczies, S Badve, ... Modern Pathology 29 (10), 1155-1164, 2016 | 270 | 2016 |
| The histophysiology and pathophysiology of the peritoneum J Van Baal, KK Van de Vijver, R Nieuwland, CJF Van Noorden, ... Tissue and Cell 49 (1), 95-105, 2017 | 221 | 2017 |
| Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 17, 2020 | 131 | 2020 |
| Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors JA Bennett, AC Braga, A Pinto, K Van de Vijver, K Cornejo, A Pesci, ... The American journal of surgical pathology 42 (10), 1370-1383, 2018 | 130 | 2018 |
| Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review JOAM van Baal, CJF van Noorden, R Nieuwland, KK Van de Vijver, ... Journal of Histochemistry & Cytochemistry 66 (2), 67-83, 2018 | 122 | 2018 |
| No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands M Timmermans, GS Sonke, KK Van de Vijver, MA Van der Aa, ... European journal of cancer 88, 31-37, 2018 | 122 | 2018 |
| Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre … LM Van Roozendaal, MLG Vane, T Van Dalen, JA van der Hage, ... BMC cancer 17, 1-8, 2017 | 113 | 2017 |
| Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival M Sobral-Leite, K Van de Vijver, M Michaut, R van der Linden, ... Oncoimmunology 7 (12), e1509820, 2018 | 110 | 2018 |
| L1CAM expression in endometrial carcinomas: an ENITEC collaboration study LJM Van Der Putten, N Visser, K Van de Vijver, M Santacana, P Bronsert, ... British journal of cancer 115 (6), 716-724, 2016 | 108 | 2016 |
| A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer RD Brandão, J Veeck, KK Van de Vijver, P Lindsey, B De Vries, ... Breast cancer research 15, 1-12, 2013 | 106 | 2013 |
| Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes M Sobral-Leite, I Salomon, M Opdam, DT Kruger, KJ Beelen, ... Breast Cancer Research 21, 1-12, 2019 | 100 | 2019 |
| Expression of aberrantly glycosylated Mucin‐1 in ovarian cancer CHMJ Van Elssen, PWH Frings, FJ Bot, KK Van de Vijver, MB Huls, ... Histopathology 57 (4), 597-606, 2010 | 92 | 2010 |
| Difficulties with diagnosis of malignancies in pregnancy J de Haan, V Vandecaveye, SN Han, KK Van de Vijver, F Amant Best Practice & Research Clinical Obstetrics & Gynaecology 33, 19-32, 2016 | 91 | 2016 |
| The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07) LM Van Roozendaal, JHW de Wilt, T Van Dalen, JA Van der Hage, ... BMC cancer 15, 1-8, 2015 | 87 | 2015 |
| European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer I Vergote, A González-Martín, I Ray-Coquard, P Harter, N Colombo, ... Annals of Oncology 33 (3), 276-287, 2022 | 85 | 2022 |
Hugo M. HorlingsMD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsGeverifieerd e-mailadres voor nki.nl
